26 Recruiting Trials

Clinical Trials
for Parkinson's in Michigan

26 clinical trials for Parkinson's are currently recruiting participants at study sites in Michigan. Study-related care is provided at no cost.

26
Recruiting trials
16
Study sites
3
Cities
15
Industry-sponsored
11
Phase 2
4
Phase 3

Parkinson's clinical trials in Michigan: what to expect

Parkinson's trials fall into three groups. Disease-modifying studies test drugs meant to slow progression, including treatments aimed at alpha-synuclein, repurposed diabetes drugs and therapies for people with LRRK2 or GBA gene variants. Symptom studies test new ways to smooth out "off" periods and dyskinesia, and procedures such as focused ultrasound and deep brain stimulation. And a large number of studies involve no medicine: exercise, speech and balance programs, wearables, and long-term observational studies that track the disease.

In Michigan, recruiting parkinson's studies are concentrated in Farmington Hills, Ann Arbor and East Lansing. 15 of the 26 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who Parkinson's trials usually look for

Disease-modifying trials usually enroll people diagnosed in the last two to five years, sometimes before any Parkinson's medicine has started. Symptom trials want people on levodopa who have a stated number of hours of "off" time a day. Most set ages 30 to 80, exclude dementia and atypical parkinsonism, and may require a dopamine transporter scan to confirm the diagnosis. Genetic trials test for the variant at no cost. Exercise and observational studies accept a much wider range.

What taking part involves

Screening includes a movement exam, sometimes performed both before and after your morning dose, blood work and a scan. Drug trials run twelve weeks to two years with monthly visits, symptom diaries and, in some, a spinal fluid test. Placebo arms are common and medicines you already take generally continue. Exercise and rehabilitation trials involve sessions two or three times a week for several months. Everything study-related is free and travel is usually reimbursed; a care partner is welcome and sometimes required.

Questions worth asking the study team

Whether you must skip a dose before visits; whether your current medicines continue; what the chance of placebo is and whether an extension follows; how many visits are required; and whether you will be told the results of any scans or genetic tests.

Showing 20 of 26 recruiting Parkinson's trials in Michigan

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
PHASE3 Birmingham, Alabama +4 sites NCT07174310
This trial is looking for people with early-stage Parkinson's disease who are currently on stable treatment with levodopa. Participants will receive either the drug prasinezumab or a placebo to study its effects.
Recruiting
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
PHASE2 Farmington Hills, Michigan +1 sites NCT07514858
This trial is looking for adults with Parkinson's disease who have motor fluctuations even while taking their usual medications. Participants will take Lu AF28996 in addition to their current treatment to see if it helps control their movement symptoms better.
Recruiting
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
PHASE1 Farmington Hills, Michigan +4 sites NCT06565195
This trial is looking for healthy volunteers and patients with Parkinson's disease to evaluate the safety and effects of a drug called LY3962681. Participants will receive either the drug or an inactive substance and will be followed up for medical assessments over time.
Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
N/A Birmingham, Alabama +4 sites NCT04994015
This trial is looking for people with Parkinson's disease who are willing to undergo genetic testing. Participants will help build a genetic database for future research on the condition.
Recruiting
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
N/A Phoenix, Arizona +4 sites NCT07330258
This trial is looking for people with Parkinson's disease who still have movement symptoms even though they are on medication. Participants will help researchers understand how the condition changes over time without altering their current treatment.
Recruiting
A Study of Buntanetap in Participants With PD
PHASE2 Birmingham, Alabama +4 sites NCT07284784
This trial is looking for adults with Parkinson's Disease who are either already on deep brain stimulation treatment or have participated in earlier trials with buntanetap. Participants will take the medication for 36 months and attend regular check-ups.
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
PHASE3 Scottsdale, Arizona +4 sites NCT06944522
This trial is looking for adults with Parkinson's Disease who are between 45 and 75 years old. Participants will receive a treatment called bemdaneprocel to see how well it works and if it is safe.
Recruiting
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
PHASE4 Tucson, Arizona +4 sites NCT04373317
This trial is looking for veterans aged 40 or older who have Parkinson's disease and experience symptoms like hallucinations or delusions. Participants will take either Pimavanserin or Quetiapine, and will need to attend study visits regularly.
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
PHASE2 Sun City, Arizona +4 sites NCT06680830
This trial is looking for men and women aged 40-80 who have early Parkinson's Disease and a specific genetic profile. Participants will take part in a study to evaluate the safety and effectiveness of a new treatment called NEU-411.
Recruiting
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
PHASE1 Farmington Hills, Michigan +4 sites NCT07422675
This trial is looking for people with Parkinson's disease who experience motor fluctuations. Participants will receive a single dose of the medication SER-252 and will be monitored for safety and effectiveness.
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
PHASE2 Birmingham, Alabama +4 sites NCT06976268
This trial is looking for adults aged 40 to 80 with early Parkinson's disease. Participants will receive treatment over 48 weeks, followed by another 48 weeks of open access to the treatment.
Recruiting
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
PHASE2 Little Rock, Arkansas +4 sites NCT07432958
This trial is looking for people with Parkinson's disease who have motor fluctuations while taking their medication. Participants will receive either the study drug AP-472 or a placebo for about 12 weeks to see how well it works.
Recruiting
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
PHASE2 Ann Arbor, Michigan +4 sites NCT07005180
This trial is looking for people between the ages of 40 and 80 who have been diagnosed with Parkinson's disease and have been using a specific Parkinson's medication for at least a month. It’s important that they haven’t smoked in the last five years and that they are generally in good health. Also, they need to have someone at home who can help keep an eye on them after taking the medication.
Recruiting
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
PHASE2 Phoenix, Arizona +4 sites NCT06285643
This trial is looking for adults aged 45-75 with moderate Parkinson's disease. Participants will receive a treatment involving a surgical procedure and will be monitored for safety and effectiveness.
Recruiting
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
PHASE1 Ann Arbor, Michigan NCT07154511
This trial is looking for adults with Parkinson's disease who have mild memory problems. Participants will take a supplement called tributyrin three times a day for about 3 months and complete tests about their thinking and movement.
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
PHASE4 Phoenix, Arizona +4 sites NCT06765668
This trial is looking for participants with Parkinson's disease who have regular 'off' periods where symptoms worsen. Taking part involves evaluating the effects of a medication called CREXONT over a period of time.
Recruiting
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
PHASE1 Los Alamitos, California +4 sites NCT06809400
This trial is looking for healthy individuals and those with Parkinson's disease. Participants will receive an infusion of the study drug or a placebo to help researchers understand safety and effects.
Recruiting
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
PHASE1 Ann Arbor, Michigan NCT07543861
This trial is looking for people with Parkinson's disease to learn about their experience using a special standing desk. Participants will attend 12 sessions to see how different types of standing affect walking ability.
Recruiting
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
N/A Birmingham, Alabama +4 sites NCT04477785
This trial is looking for people with Parkinson's disease, healthy volunteers, or those at risk of Parkinson's. Participants will help researchers understand how the disease progresses and identify markers for future treatments.
Recruiting
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PHASE2 Scottsdale, Arizona +4 sites NCT07804615
This trial is looking for adults with Parkinson's disease who have tremors that are not well-managed with current treatments. Participants will be given a study medication to see if it helps improve their symptoms and daily life.
Recruiting

Where the Parkinson's studies are in Michigan

  • Quest Research Institute, Farmington Hills8 trials
  • University of Michigan, Ann Arbor7 trials
  • Domino's Farms, Ann Arbor3 trials
  • Michigan State University, East Lansing2 trials
  • Michigan Clinical Research Unit - Neurology, Ann Arbor1 trial
  • Michigan State University (Neurology), East Lansing1 trial

Counts are recruiting studies listing at least one site in Michigan, from ClinicalTrials.gov, refreshed every two days.

Parkinson's clinical trials in Michigan: common questions

How many Parkinson's clinical trials are recruiting in Michigan?
TrialFinder currently lists 26 recruiting Parkinson's clinical trials with study sites in Michigan. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Parkinson's clinical trials located in Michigan?
Study sites for the Parkinson's trials listed on this page include Farmington Hills, Ann Arbor. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Parkinson's clinical trial in Michigan?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Parkinson's trials in Michigan also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Parkinson's clinical trial in Michigan?
Each study sets its own criteria based on age, Parkinson's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a Parkinson's trial if I take carbidopa-levodopa?
Yes for most trials, including every study of "off" time. Some disease-modifying trials want people who have not started medicine yet; the listing says so.
What does "off time" mean in a trial listing?
The hours each day when your medicine has worn off and symptoms return. Trials of new symptom treatments usually require about two or more hours of off time a day, recorded in a diary during screening.
Are there Parkinson's trials that do not involve medicine?
Many. Exercise, speech, balance and dance programs, wearable sensors, deep brain stimulation settings and observational studies all recruit, and most accept people at any stage who can attend sessions.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Parkinson's trials near you in Michigan.

Get Matched — Free
No insurance required

Parkinson's disease trials test dopamine-replacement therapies, deep brain stimulation, gene therapies, and neuroprotective compounds to slow disease progression.

All Parkinson's trials →